Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Other

Ramot University Authority for Applied Research and Industrial

Universidade Federal Do Rio Grande Do Sul-ufrgs

Universidade De São Paulo-Usp

Hadasit Medical Research Services and Development Ltd.

Pharmos Corporation

Institut National De La Sante Et De La Recherche Medicale

University of Guelph

Ariel Corporation

Aristotle University of Thessaloniki

Epm (ip), Inc.

Ariel-university Research and Development Company Ltd.

Burstein, Sumner H.

Raphael Mechoulam

Aviva Breuer

Ruth Gallily

Esther Shohami

Itai A Bab

Ester Fride

Lumir Hanus

Sumner H Burstein

Mordechai Sokolovsky

Aaron Garzon

Susanna Tchilibon

Anat Biegon

Flavio Pereira Kapczinski

Joseph Tam

Yoel Kloog

Jaime Eduardo Cecilio Hallak

Jose Alexandre De Souza Crippa

Francisco Silveira Guimaraes

Reem Smoum

Michal Horowitz

Linda Parker

Naphtali Lander

Antonio Waldo Zuardi

Shabtay Dikstein

Andreas Zimmer

William Devane

Lital Magid

Jeffery J Feigenbaum

Yaron Ilan

Shimon Slavin

Marc Feldmann

Vincenzo Di Marzo

Simon Benita

Chaim Lotan

Yosefa Avraham

Elliot Berry

Lola Weiss

Shimon Ben Shabat

Yossi Dagon

Yinon Ben Neriah

William A Devane

Lemir Hanus

Aviva Beuer

Abraham Abrahamov

Benyamin Shalita

Morris Srebnik

Ruth Rabinowitz

Dror Robinson

Dan Peer

Aron H Lichtman

Michael Schlesinger

Gary Milman

Michael Zeira

Susana Tchilibon

Imad M Damaj

Meliha Karsak

Marie-Christine De Vernejoul

G R Barrie Webster

Leonard P Sarna

Roger Pertwee

Aron Weller

Christeen Haj

Saja Baraghithy

Iddo Magen

David Panikashvili

Tzviel Sheskin

Nicholas Grigoriadis

Esther Fride

Natalya M Kogan

Theofilos Poutachidis

Anne-Marie Malfait

Fabiana Piscitelli

Rami Yaka

Emil Pop

Naama Mussai

Jeffrey J Feigenbaum

Arik Moussaieff

Eran Leitersdorf

Vardiella Meiner

Ronen Durst

Thea Pugatsch

Jose Alexandre Crippa

Jaime Eduardo Hallak

Linda Department Of Psychology Parker

The present disclosure provides pharmaceutical compositions including a cannabinoid acid ester compound alone or in combination with one or more additional cannabinoid compounds. In some embodiments, the cannabinoid acid ester compound is a cannabidiolic acid ester. A variety of therapeutic applications in which the cannabinoid acid ester compounds and pharmaceutical compositions find use are also provided, including combination therapies using cannabinoid acid ester compounds and one or more additional therapeutic agents.

Cannabinoid acid ester compositions and uses thereof

Cannabidiolic acid esters, compositions comprising them and uses thereof in the treatment of various diseases, conditions and symptoms.

Cannabidiolic acid esters compositions and uses thereof

The present invention is directed to a fatty acid amide of an amino acid, including a stereoisomer and a salt thereof for use in the treatment of a patient suffering from any type of addiction disorder, substance abuse disorder, including any condition and symptom associated therewith and including withdrawal syndrome and relapse addiction during and after a rehabilitation treatment of said patient.

Fatty acid amides and uses thereof in the treatment of addiction disorder and addiction related conditions

Compositions that include certain phenyl substituted cyclohexenyl compounds are administered to a subject in a method for treating obesity or an associated disease or disorder or in a method of reducing food consumption or body weight.

Method for treating pain or associated condition or symptom

The present disclosure provides pharmaceutical compositions comprising a fatty acid amide of an amino acid as defined herein, such as oleoyl-&#x3b1;-methyl-serine, or a stereoisomer or salt thereof, for improving, as in increasing or preventing loss of, bone mineral density and/or treating osteoporosis in patients suffering from Prader-Willi syndrome; and their methods of use.

Methods for treatment of Prader-Willi syndrome

The present invention relates to fluorine substituted CBD compounds, compositions thereof and uses thereof for the preparation of medicaments.

Fluorinated CBD compounds, compositions and uses thereof

Cyclohexenyl compounds, compositions comprising them and uses thereof

The compounds D9-tetrahydrocannabinol (THC), cannabidiol (CBD) and capsaicin are useful for prevention, treatment, or both, of hepatic encephalopathy. The compounds capsaicin, 2-arachidonoylglycerol (2-AG), HU-308 and cannabidiol are useful for prevention, treatment, or both, of liver cirrhosis.

Treatment of hepatic encephalopathy and liver cirrhosis

Provided are compositions including (3R, 4R, 6R)-stereoisomers of phenyl substituted pinenes having CB receptor agonist properties, methods of treating diseases or disorders with the pharmaceutical compositions, and processes for their preparation are also provided.

Compositions comprising CB receptor agonists, uses thereof and methods for their preparation

The present invention relates to arylated camphenes, processes for their preparation and uses thereof for the manufacture of medicaments for the treatment of diseases, disorders or conditions associated with, or benefiting from stimulation of CB2 receptors.

Arylated camphenes, processes for their preparation and uses thereof

The present invention relates to cannabinoic quinone compounds, and especially to their medical use. In particular five cannabinoic quinones, designated HU-331, HU-336, HU-345, HU-395 and HU-396, are described as active agents in pharmaceutical compositions. These compounds and compositions thereof are intended for the treatment of inflammatory, infectious, auto-immune and particularly hyperproliferative disorders. Thus, the compounds of the invention may be used as anti-tumor agents, or for the treatment of cancer. Furthermore, three of these compounds, HU-345, HU-395 and HU-396, are novel cannabinoic quinones.

Compositions including quinonoid derivatives of cannabinoids for therapeutic use

Provided are fatty acid amides of amino acids, uses thereof and pharmaceutical compositions including them.

Fatty acid amides and uses thereof

Growing community of inventors

Jerusalem, Israel

Raphael Mechoulam